Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?

AIM: Bladder cancer is the second most common urological malignancy after prostate cancer. Increase in the post-void residual (PVR) volume may result in an increase in the risk of cancer recurrence. METHODS: Patient demographic data, tumor stage and grade, PVR volume and 2 years follow-up data for r...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Zubi, Mohammad Talal, Demour, Saddam Al, Al-Rawashdah, Samer Fathi, Carbone, Antonio, Pastore, Antonio Luigi, Abuhamad, Mohannad, Abuorouq, Saleh, Al-Azab, Rami, Bani-Hani, Morad, Al-Qudah, Mohammad, Elayan, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912276/
https://www.ncbi.nlm.nih.gov/pubmed/36788983
http://dx.doi.org/10.2144/fsoa-2022-0045
Descripción
Sumario:AIM: Bladder cancer is the second most common urological malignancy after prostate cancer. Increase in the post-void residual (PVR) volume may result in an increase in the risk of cancer recurrence. METHODS: Patient demographic data, tumor stage and grade, PVR volume and 2 years follow-up data for recurrence were obtained and evaluated. RESULTS: One-hundred-and-nineteen patients were subdivided into three groups according to PVR urine volume. The increase of PVR volume was related to short recurrence-free survival (RFS) especially for patients with PVR volume of 60 ml or more. CONCLUSION: Low PVR volume in patients with non-muscle invasive bladder cancer may play a role in reducing cancer recurrence. However further research is needed in this field.

Ejemplares similares